Trial intelligence / Profile preview

Preoperative Combined Iron Therapy in Anemic Patients Undergoing Cardiac Surgery

NCT06968936Recruiting

Sponsor
Second Affiliated Hospital of Zhejiang University School of Medicine
Start
Mar 2026
Primary completion
Jun 2029
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of iron sucrose, erythropoietin and ascorbic acid in iron deficiency anemia (IDA) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Quality of Life at 1 year. Started Mar 2026; status: recruiting.

02

Drugs

iron sucroseerythropoietinascorbic acid
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT06968936.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06968936.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call